株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫治療薬の世界市場

Immunotherapy Drugs

発行 Global Industry Analysts, Inc. 商品コード 893746
出版日 ページ情報 英文 94 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
免疫治療薬の世界市場 Immunotherapy Drugs
出版日: 2019年10月01日 ページ情報: 英文 94 Pages
概要

当レポートでは世界の免疫治療薬市場について調査分析を行い、市場概要、市場動向、今後の見通しなどについて考察するとともに、米国、カナダ、日本、欧州、アジア太平洋地域、世界のその他の諸国の各市場について分析し、主要企業のプロファイルなどについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界の企業市場シェア
      • 世界の免疫治療薬市場シェアのシナリオ
  • 主要企業
  • 市場動向と促進因子
  • 世界市場の見通し

第3章 市場分析

  • 地域市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • 欧州のその他の諸国
  • アジア太平洋地域
  • 世界のその他の諸国

第4章 競合

  • ABBVIE
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG

第5章 まとめ

目次
Product Code: MCP12540

Immunotherapy Drugs market worldwide is projected to grow by US$198 Billion, driven by a compounded growth of 13.7%. Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 14.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$175.9 Billion by the year 2025, Cancer will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 14.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$7.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$9.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cancer will reach a market size of US$13.6 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.5% over the next couple of years and add approximately US$34.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, AbbVie, Inc.; Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Immunotherapy Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Immunotherapy Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Immunotherapy Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Immunotherapy Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Cancer (Therapy Area) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Cancer (Therapy Area) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Cancer (Therapy Area) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Autoimmune & Inflammatory Diseases (Therapy Area) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Autoimmune & Inflammatory Diseases (Therapy Area) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Autoimmune & Inflammatory Diseases (Therapy Area) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Infectious Diseases (Therapy Area) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Infectious Diseases (Therapy Area) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Infectious Diseases (Therapy Area) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Other Therapy Areas (Therapy Area) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Other Therapy Areas (Therapy Area) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Other Therapy Areas (Therapy Area) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Immunotherapy Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 16: United States Immunotherapy Drugs Market Estimates and Projections in US$ Million by Therapy Area: 2018 to 2025
    • TABLE 17: Immunotherapy Drugs Market in the United States by Therapy Area: A Historic Review in US$ Million for 2009-2017
    • TABLE 18: United States Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 19: Canadian Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018 to 2025
    • TABLE 20: Canadian Immunotherapy Drugs Historic Market Review by Therapy Area in US$ Million: 2009-2017
    • TABLE 21: Immunotherapy Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapy Area for 2009, 2019, and 2025
  • JAPAN
    • TABLE 22: Japanese Market for Immunotherapy Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2018-2025
    • TABLE 23: Immunotherapy Drugs Market in Japan: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2009-2017
    • TABLE 24: Japanese Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 25: Chinese Immunotherapy Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2018-2025
    • TABLE 26: Immunotherapy Drugs Historic Market Analysis in China in US$ Million by Therapy Area: 2009-2017
    • TABLE 27: Chinese Immunotherapy Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Immunotherapy Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 28: European Immunotherapy Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 29: Immunotherapy Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 30: European Immunotherapy Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 31: European Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018-2025
    • TABLE 32: Immunotherapy Drugs Market in Europe in US$ Million by Therapy Area: A Historic Review for the Period 2009-2017
    • TABLE 33: European Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 34: Immunotherapy Drugs Market in France by Therapy Area: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 35: French Immunotherapy Drugs Historic Market Scenario in US$ Million by Therapy Area: 2009-2017
    • TABLE 36: French Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 37: Immunotherapy Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Area for the Period 2018-2025
    • TABLE 38: German Immunotherapy Drugs Historic Market Analysis in US$ Million by Therapy Area: 2009-2017
    • TABLE 39: German Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 40: Italian Immunotherapy Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2018-2025
    • TABLE 41: Immunotherapy Drugs Historic Market Analysis in Italy in US$ Million by Therapy Area: 2009-2017
    • TABLE 42: Italian Immunotherapy Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 43: United Kingdom Market for Immunotherapy Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2018-2025
    • TABLE 44: Immunotherapy Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2009-2017
    • TABLE 45: United Kingdom Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018-2025
    • TABLE 47: Immunotherapy Drugs Market in Rest of Europe in US$ Million by Therapy Area: A Historic Review for the Period 2009-2017
    • TABLE 48: Rest of Europe Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Immunotherapy Drugs Market in Asia-Pacific by Therapy Area: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 50: Asia-Pacific Immunotherapy Drugs Historic Market Scenario in US$ Million by Therapy Area: 2009-2017
    • TABLE 51: Asia-Pacific Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 52: Rest of World Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018 to 2025
    • TABLE 53: Rest of World Immunotherapy Drugs Historic Market Review by Therapy Area in US$ Million: 2009-2017
    • TABLE 54: Immunotherapy Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Area for 2009, 2019, and 2025

IV. COMPETITION

  • ABBVIE
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO.
  • NOVARTIS INTERNATIONAL AG

V. CURATED RESEARCH

Back to Top